On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

NKT Therapeutics (United States)

InstitutionResearch output, impact & collaborations

NKT Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about NKT Therapeutics (United States)?

ScholarIQrecord summary

NKT Therapeutics (United States) is a research organisation in Waltham, United States. OpenAlex records 248 works and 313,996 citations for it. 5 researchers list it as their most recent affiliation.

How many works does NKT Therapeutics (United States) have?

ScholarIQindexed works

NKT Therapeutics (United States) has 248 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for NKT Therapeutics (United States) →

How many citations does NKT Therapeutics (United States) have?

ScholarIQcitation count

NKT Therapeutics (United States) has 313,996 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for NKT Therapeutics (United States) →

How many researchers are at NKT Therapeutics (United States)?

ScholarIQresearcher count

NKT Therapeutics (United States) has 5 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at NKT Therapeutics (United States)?

ScholarIQavg h-index

NKT Therapeutics (United States) has an average h-index of 50.6 in OpenAlex.

Open the OpenAlex record →

What is the ROR of NKT Therapeutics (United States)?

ScholarIQror

The ROR for NKT Therapeutics (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for NKT Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for NKT Therapeutics (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind NKT Therapeutics (United States)?

ScholarIQtop researchers by citations

Jeffery L. Kutok · Chronic Lymphocytic Leukemia Research

412 works31,649 citations

Edmund J. Lewis · Renal Diseases and Glomerulopathies

231 works28,203 citations

Keith G. Weinstock · Fungal and yeast genetics research

18 works27,556 citations

JoAnn Dubois · Genomics and Phylogenetic Studies

7 works26,602 citations

David P. Nicolau · Antibiotics Pharmacokinetics and Efficacy

912 works24,540 citations

What are the most-cited papers on NKT Therapeutics (United States)?

ScholarIQmost cited works

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke, Tomás Berl, Marc A. Pohl, Julia B. Lewis, Eberhard Ritz, Robert C. Atkins, Richard Rohde, Itamar Raz

New England Journal of Medicine. 20016,021 CitationsOPEN ACCESS

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

Hans‐Henrik Parving, Frederik Persson, Julia B. Lewis, Edmund J. Lewis, Norman K. Hollenberg

New England Journal of Medicine. 20081,105 CitationsOPEN ACCESS

Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells

Ann Mullally, Steven Lane, Brian Ball, Christine Megerdichian, Rachel Okabe, Fátima Al‐Shahrour, Mahnaz Paktinat, J. Erika Haydu, Elizabeth Housman, Allegra M. Lord, Gerlinde Wernig, Michael G. Kharas, Thomas Mercher, Jeffery L. Kutok, D. Gary Gilliland, Benjamin L. Ebert

Cancer Cell. 2010395 CitationsOPEN ACCESS

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial

Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier, Fernando de Álvaro, Giacomo Deferrari, Gilbert M. Eisner, Enric Esmatjes, Richard E. Gilbert, Lawrence G. Hunsicker, José B. Lopes de Faria, Ruggero Mangili, Jack Moore, Efrain Reisin, Eberhard Ritz, Guntram Schernthaner, Samuel Spitalewitz, H Tindall, Roger A. Rodby, Edmund J. Lewis

Journal of the American Society of Nephrology. 2005375 Citations

Effects of RAS on the genesis of embryonal rhabdomyosarcoma

David M. Langenau, Matthew D. Keefe, Narie Y. Storer, Jeffrey R. Guyon, Jeffery L. Kutok, Xiuning Le, Wolfram Goessling, Donna Neuberg, Louis M. Kunkel, Leonard I. Zon

Genes & Development. 2007332 CitationsOPEN ACCESS

How much of the research on NKT Therapeutics (United States) is open access?

ScholarIQopen access share

75%OPEN ACCESS

Gold

13%

Green

25%

Hybrid

Bronze

38%

Closed

25%